Kebbi malaria cases fall from 49% to 18% as vaccine rollout widens
Combining seasonal chemoprevention with the R21 vaccine produced a 30.6 percentage-point drop in the state between 2021 and 2025, as the programme expands into Bauchi and Ondo.
Matching Articles (4) for “Malaria”
Combining seasonal chemoprevention with the R21 vaccine produced a 30.6 percentage-point drop in the state between 2021 and 2025, as the programme expands into Bauchi and Ondo.
The evidence from Kebbi is about as good as public health evidence gets. What decides the next five years is cold chains, staffing and whether families come back for dose four.
The R21 programme has moved beyond its first two states, with the vaccine folded into routine immunisation rather than run as a separate campaign.
A new study has raised concerns over the continued impact of malaria on newborns in Nigeria, with researchers finding that congenital malaria remains a significant public health concern and calling for stronger prevention, surveillance and treatment during pregnancy and after childbirth.